EARNING RECAP

3M co

#MMM 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q1 adjusted $2.23 est. $2.49 $7.9B est. $8.02B -12.95% ($190.72 closing price) $198.96 $189.60 cuts FY19 adjusted view to $9.25- $9.75 from $10.45 -$10.90 est. $10.52; cuts 2K position Worldwide
#MMM 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted $2.31 est. $2.28 $7.9B est. $7.87B +1.94% ($196.95 closing price) $199.89 $194.20 cuts Fy19 EPS view to $10.45- $10.90 from $10.60- $11.05
Q3 GAAP $2.58 est. $2.70 $8.2B est. $8.39B -4.38% ($192.55 closing) $194.89 $184.50 52 weeks low; lowers FY18 adjusted EPS view $9.90-$10.00 from $10.20-$10.45
Q2 adjusted $2.59 est. $2.58 $8.39B est. $8.37B +.93% ($200.68 closing) $202.19 $190.57 narrows FY adjusted EPS view to $10.20-$10.45 from $10.20-$10.55; FY EPS consensus is $10.34, revenue $33.33B
Q1 adjusted $2.50 est. $2.51 $8.3B est. $8.25B -6.83% ($201.13 closing) $206.50 $196.89 adjusted FY18 earnings to $10.20-$10.55 from $10.20-$10.70,organic local currency sales growth guidance 3%-4% from 3%-5%
#MMM 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 ADJ eps $2.10 VS $2.02 $8b VS $7.83b +1.89% ($252.36 closing) $254.80 $247.10 boosts FY EPS view to $10.20-$10.70 form $9.60-$10.00
Q3 $2.33 VS $2.21 $8.2B Vs $7.93B +5.91% ($234.65 closing) $238.90 records 10 years highs $228.90 Boosts FY17 EPS view to $9.00-$9.10 from $8.80-$9.05
Q2 $2.58 Vs $2.59 $1.58B Vs $1.60B -5.05% ($199.39 closing) $204.50 $197.17 Missed after 8 quarter beats. Company sees revenue in range of $165M to $174M.
Q1 $2.16 VS $2.06 est $7.70B vs $7.47B est +0.46% ($195.13 closing) $195.61 $192.36 Stock popped but faded as closed

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.